Search hospitals > New Jersey > Ridgewood
Neurosurgeons of New Jersey-Ridgewood
Claim this profileRidgewood, New Jersey 07450
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Breast Cancer
Conducts research for Recurrence
Conducts research for Non-Small Cell Lung Cancer
24 reported clinical trials
2 medical researchers
Summary
Neurosurgeons of New Jersey-Ridgewood is a medical facility located in Ridgewood, New Jersey. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Neurosurgeons of New Jersey-Ridgewood is involved with conducting 24 clinical trials across 72 conditions. There are 2 research doctors associated with this hospital, such as Eleonora Teplinsky, MD and Jason Suh.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Stage II
Stage III
Stage I
Top PIs
Eleonora Teplinsky, MDThe Valley Hospital-Luckow Pavilion4 years of reported clinical research
Studies Breast Cancer
Studies Cancer
14 reported clinical trials
33 drugs studied
Jason SuhThe Valley Hospital-Luckow Pavilion5 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
6 reported clinical trials
18 drugs studied
Clinical Trials running at Neurosurgeons of New Jersey-Ridgewood
Lung Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Cancer
Breast Cancer
Squamous Cell Carcinoma
Lung Carcinoma
ALK Gene Rearrangement
Recurrence
Multiple Myeloma
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Neurosurgeons of New Jersey-Ridgewood?
Neurosurgeons of New Jersey-Ridgewood is a medical facility located in Ridgewood, New Jersey. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Neurosurgeons of New Jersey-Ridgewood is involved with conducting 24 clinical trials across 72 conditions. There are 2 research doctors associated with this hospital, such as Eleonora Teplinsky, MD and Jason Suh.